BRIEF-Lexicon Pharmaceuticals says Xermelo 250 mg has been included as a recommended treatment option in latest national comprehensive cancer network

* Lexicon Pharmaceuticals Inc - Xermelo 250 mg has been included as a recommended treatment option in latest national comprehensive cancer network
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.